How Do Probiotics Affect Gut Health?
Quick answer
Certain probiotic strains such as Akkermansia, Streptococcus thermophilus ST10, Lactobacillus delbrueckii subsp. bulgaricus, and Bifidobacterium show potential benefits for gut health by improving intestinal permeability and gut barrier function, though evidence varies by condition and strain.
🔬 What the research shows
High-quality systematic reviews and randomized controlled trials indicate that probiotics can influence gut health by modulating intestinal permeability and gut barrier integrity. Akkermansia shows promise in reducing intestinal permeability associated with obesity, though clinical trial results are inconsistent. Streptococcus thermophilus ST10 combined with tara gum significantly improved intestinal barrier function in healthy subjects. Lactobacillus delbrueckii subsp. bulgaricus-containing probiotics improved mucosal barrier function in diarrhea-predominant IBS patients. Bifidobacterium is commonly found in formulations that improve gut microbiota and reduce permeability, especially in older adults. However, some studies, such as probiotic use to prevent aspirin-induced permeability increases or in chronic kidney disease, show uncertain or no clear benefits. Evidence quality varies, and strain-specific effects are important. More standardized, larger trials are needed.
Best studied probiotic strains
Akkermansia
Systematic review (PMID: 38072119) found Akkermansia among strains that reduced intestinal permeability in obesity models, though clinical trial results were mixed.
More standardization in dosage and delivery is needed to confirm effects in humans.
Streptococcus thermophilus ST10
RCT (PMID: 25291130) showed significant improvement in intestinal permeability and increased exopolysaccharides in healthy subjects after 30 days of supplementation.
Pilot study; larger trials in subjects with impaired gut permeability are needed.
Lactobacillus delbrueckii subsp. bulgaricus
RCT (PMID: 18671775) demonstrated decreased small bowel permeability and improved symptoms in diarrhea-predominant IBS patients after 4 weeks of probiotic treatment.
Part of a multi-strain probiotic formulation; effects specific to small bowel permeability.
Bifidobacterium
Systematic reviews (PMID: 38072119, 39305569) report Bifidobacterium as a common beneficial genus in probiotics improving gut microbiota diversity and reducing intestinal permeability, especially in older adults.
Evidence supports benefits but strain-specific data are limited.
👥 Who may benefit
✅ Safety
Probiotic supplementation was generally safe with minimal and non-serious adverse events reported, such as mild gastrointestinal symptoms (flatulence, nausea, diarrhea, abdominal pain). No serious safety concerns were identified in the reviewed studies.
⚠️ Limitations
Evidence is limited by heterogeneity in probiotic strains, dosages, treatment durations, and study populations. Some clinical trials showed inconsistent or uncertain results. Many studies had small sample sizes or were pilot trials. More high-quality, standardized RCTs are needed to confirm strain-specific effects and long-term benefits. Data on some populations, such as solid organ transplant recipients and chronic kidney disease patients, are insufficient to draw conclusions.